LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A (LFMDP) has a PEG ratio of -2.49, below the Healthcare sector average of 2.8.
Get informed when a big investor buys or sells
+ Follow-2.49
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for LFMDP is -2.49. That is below the Healthcare sector average of 2.8. Investors often review this figure alongside LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, LFMDP currently prints -2.49 for PEG ratio, while the sector average sits near 2.8. That is roughly 189.0% below the sector mean. Large gaps often invite a closer look at LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's growth, margins, and balance sheet.
A PEG ratio of -2.49 for LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A is not 'good' or 'bad' on its own. Compare it with the peer average (2.8) and with LFMDP's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting LFMDP's PEG ratio (-2.49), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.